What's new

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised

Feb 26, 2025 - 11:45
 0
Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Kiniksa adds to Sjögren's exodus with trial termination, axes AstraZeneca asset

Next Article

Human medicines European public assessment report (EPAR): Duaklir Genuair, aclid...

Related Posts

ICH M12 on drug interaction studies - Scientific guideline

ICH M12 on drug interaction studies - Scientific guideline

Feb 13, 2025  0

Clinical Trial Information System (CTIS) evaluation tim...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 10, 2025  0